Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004562332 | SCV000211906 | likely benign | Familial adenomatous polyposis 1 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000163381 | SCV000213921 | likely benign | Hereditary cancer-predisposing syndrome | 2014-06-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000679057 | SCV000512071 | likely benign | not provided | 2020-03-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163381 | SCV000681618 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679057 | SCV000805400 | likely benign | not provided | 2016-11-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000679057 | SCV001133326 | benign | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000440935 | SCV001361160 | benign | not specified | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163381 | SCV002533847 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-12 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003998533 | SCV004837813 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562332 | SCV004932021 | benign | Familial adenomatous polyposis 1 | 2024-03-21 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Center for Genomic Medicine, |
RCV000440935 | SCV005090695 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000679057 | SCV005226891 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV001353704 | SCV000591149 | likely benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The APC p.Thr1208Thr variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site; in addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The variant was identified in the Exome Aggregation Consortium (ExAC) database in 23 of 66362 chromosomes from a population of European (non-Finnish) individuals (frequency: 0.0003), and in the the ClinVar database where it was classified as a likely benign variant by two submitters (Invitae and Ambry Genetics). The variant was not identified in the literature, nor was it identified in any other databases searched. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as predicted benign. | |
Clinical Genetics, |
RCV000679057 | SCV001922484 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679057 | SCV001957342 | likely benign | not provided | no assertion criteria provided | clinical testing |